Sort
85,873 grants matching “alzheimers”
Imaging epigenetic dysregulation in the Lewy body dementias with [11C]Martinostat
$827,629Stephen N. Gomperts · Massachusetts General Hospital · R01 · FY2024 · AG
Sleep Quality and Mechanistic Links to Alzheimer Disease and Related Disorders among older Mexican Americans and Non-Hispanic Whites
$827,604Kristine Yaffe · University Of California, San Francisco · R01 · FY2019 · AG
NIH Director's Pioneer Award
$827,584Junying Yuan · Harvard Medical School · DP1 · FY2007 · OD
NIH Director's Pioneer Award
$827,584Junying Yuan · Harvard Medical School · DP1 · FY2009 · OD
NIH Director's Pioneer Award
$827,584Junying Yuan · Harvard Medical School · DP1 · FY2008 · OD
Neural Correlates of Apathy Across the Alzheimer's Disease Continuum
$827,561Gad Asher Marshall · Massachusetts General Hospital · R01 · FY2020 · AG
Hypothalamic AgRP neurons are determinants of healthy lifespan and higher brain f
$827,500Tamas L Horvath · Yale University · DP1 · FY2010 · OD
Exploring the Role of the Brain Epigenome: Cognitive Decline and Life Experiences
$827,440David A Bennett · Rush University Medical Center · R01 · FY2009 · AG
Ahead of the Curve: Early detection and monitoring of learning decrements in Alzheimers disease
$827,427Kathryn Victoria Papp · Brigham And Women'S Hospital · R01 · FY2025 · AG
Non-coding RNAs in resilience to Alzheimerâs Disease
$827,394Frank J. Slack · Beth Israel Deaconess Medical Center · R01 · FY2025 · AG
Core B - Clinical Core
$827,292David A Wolk · University Of Pennsylvania · P30 · FY2019 · AG
Structural Racism, Resilience, and Premature Cognitive Aging in End-stage Renal Disease
$827,247Mara A. McAdams Demarco · New York University School Of Medicine · R01 · FY2023 · AG
Transcriptional Control of Neuroinflammation in Alzheimer's Disease
$827,161Ming-Ming Zhou · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG
Clinical
$827,124Bruce L Miller · University Of California, San Francisco · P01 · FY2025 · AG
Characterizing Cognitive Decline in Late Life Depression: The ADNI-D Project
$827,111Robert Scott Mackin · University Of California, San Francisco · R01 · FY2013 · MH
mGluR5 and Phase State Dependent Synaptic Loss in Alzheimer's Disease
$827,048Stephen M Strittmatter · Yale University · R01 · FY2022 · AG
Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA)
$826,988Hector M Gonzalez · University Of California, San Diego · R01 · FY2019 · AG
Core B: The Clinical and Translational Research Core
$826,966Xue K Zhong · Cleveland Clinic Foundation · P20 · FY2018 · GM
Phase IIB Plasticity-based Adaptive Cognitive Remediation for Alzheimers Disease
$826,900Hyun Kyu Lee · Posit Science Corporation · R44 · FY2025 · AG
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG
$826,867Patrick L. Purdon · Massachusetts General Hospital · R01 · FY2020 · AG
Pericyte control of capillary perfusion in the Alzheimer's disease brain
$826,830Andy Y Shih · Seattle Children'S Hospital · R01 · FY2025 · AG
CHCHD10 Frontotemporal Dementia, Molecular Mechanisms and Therapeutic Strategies
$826,742Hibiki Fujita · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · NS
Development of sensitive PET tracers of pan-Amyloid-beta species for Alzheimer's disease
$826,732Chongzhao Ran · Massachusetts General Hospital · R01 · FY2024 · AG
ApoE4, Neurovascular Injury and Cognitive Impairment
$826,653Costantino Iadecola · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · NS
The long-term impact of light intervention on sleep physiology and cognition in mild cognitive impairment
$826,598Mariana Gross Figueiro · Rensselaer Polytechnic Institute · R01 · FY2019 · AG